TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/6/24 16:21 | 3/4/24 | STRO | Sutro Biopharma, Inc. | Health | BioPrd | Biological Products, (No Diag | Chung Jane | CA | O | P,COO | M.d | 0 | 0.00 | 0 | 8 | 23 | 42 | D | |||||||||||||||
3/5/24 16:32 | 3/1/24 | STRO | Sutro Biopharma, Inc. | Health | BioPrd | Biological Products, (No Diag | Chung Jane | CA | O | P,COO | M.d | 0 | 0.00 | 0 | 7 | 23 | 37 | D | |||||||||||||||
8/11/23 16:16 | 8/9/23 | STRO | Sutro Biopharma, Inc. | Health | BioPrd | Biological Products, (No Diag | Chung Jane | CA | O | Chief Co | M.d | 0 | 0.00 | 0 | 19 | 145 | 32 | D | |||||||||||||||
3/7/23 16:26 | 3/3/23 | STRO | Sutro Biopharma, Inc. | Health | BioPrd | Biological Products, (No Diag | Chung Jane | CA | O | Chief Co | M.d | 0 | 0.00 | 0 | 8 | 68 | 19 | D | |||||||||||||||
8/10/22 18:16 | 8/9/22 | STRO | Sutro Biopharma, Inc. | Health | BioPrd | Biological Products, (No Diag | Chung Jane | CA | O | Chief Co | M.d | 0 | 0.00 | 0 | 19 | 15 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |